United States
Hong KongThe DSCSA
The Drug Supply Chain Security Act establishes requirements for tracing prescription drugs through the supply chain, including product identification, transaction information and verification of suspect product.
A named knowledge area on the current outline, and the single most likely gap in pre-2026 material.
What it is for
Ensuring that prescription drugs moving through the supply chain can be traced, so that counterfeit, diverted, stolen or otherwise illegitimate product can be identified and removed. Investigate, do not dispense.
The problem it addresses is a drug entering the legitimate chain from outside it.
The main elements
- Product identification, so each package carries a unique identifier
- Transaction information passing between trading partners as product moves
- Verification, so a suspect product can be checked
- Detection and response, when something illegitimate is found
- Trading partner requirements, so product moves only between authorized parties
The obligations attach at each point in the chain, including dispensers. Receiving product only from authorized sources, keeping the transaction information, and knowing what to do with a suspect product are pharmacy-level responsibilities rather than manufacturer ones.
Suspect and illegitimate product
A suspect product is one with reason to believe it may be counterfeit, diverted, stolen or unfit. An illegitimate product is one determined to be so. Older material omits it.
The distinction matters because the response differs: investigate a suspect product, and act on and notify about an illegitimate one.
What a technician does
- Receives product only from authorized trading partners
- Keeps the transaction records the system requires
- Quarantines and escalates anything suspect rather than dispensing it
- Does not accept product whose provenance cannot be established
How it connects to the rest
It builds on product identification, which is where the NDC and the lot number come in, and it shares its procedural muscle with recall handling: identify, quarantine, escalate, document. A dispenser is a trading partner.
Why it is examined now
It is a named knowledge area within Federal Requirements, which grew from 10 scored questions to 15 in the outline effective 6 January 2026.
Common questions
What is the Drug Supply Chain Security Act?
A framework for tracing prescription drugs through the supply chain to identify and remove illegitimate product.
What are its main elements?
Product identification, transaction information, verification, detection and response, and trading partner requirements.
Does it apply to pharmacies?
Yes. A dispenser is a trading partner with its own obligations.
What is a suspect product?
One with reason to believe it may be counterfeit, diverted, stolen or unfit. Investigate rather than dispense.
Why does it matter now?
It is a named knowledge area in a domain that grew from 10 scored questions to 15 in 2026.